Work

Outcomes of post-allogeneic hematopoietic stem cell transplant (HSCT) maintenance therapy in FLT3-mutated, IDH-mutated, or high relapse-risk myeloid malignancies: A single-center experience.

Year: 2025
Type: article
Study design: Observational Study
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: closed
OpenAlex ID: W4410807968
FWCI:
Cites:
Cited by:
Related to: 10